Class IIITerminatedD-1476-2016
Drug recall · September 7, 2016
CLINIQUE moisture surge tinted moisturizer broad spectrum SPF 15 recall
Why: Subpotent Drug: Two of the active sunscreen ingredients, octinoxate and octisalate, are below the specifications for assay.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
CLINIQUE moisture surge tinted moisturizer broad spectrum SPF 15, 1 FL. OZ.LIQ./30 ml bottle within a carton, Clinique Labs., Dist. New York, N.Y., 10022; New York, London W1K 3BQ; Paris, UPC No. 20714-47479-9, Shade 04 (M-N)
- Lots / codes
all lots
- Quantity
- 1,771,244 bottles for all shades
- Company
- Clinique International, New York, NY
- Distribution
- Nationwide
- Initiated
- May 17, 2016 · Voluntary: Firm initiated
- Classified
- August 26, 2016
- Reported
- September 7, 2016
- Ended
- June 14, 2018
- How notified
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Class IIITerminatedSep 7, 2016CLINIQUE moisture surge tinted moisturizer broad spectrum SPF 15Clinique International · D-1473-2016Class IIITerminatedSep 7, 2016CLINIQUE moisture surge tinted moisturizer broad spectrum SPF 15Clinique International · D-1474-2016Class IIITerminatedSep 7, 2016CLINIQUE moisture surge tinted moisturizer broad spectrum SPF 15Clinique International · D-1475-2016Class IIITerminatedSep 7, 2016CLINIQUE moisture surge tinted moisturizer broad spectrum SPF 15Clinique International · D-1477-2016Class IIITerminatedSep 7, 2016CLINIQUE moisture surge tinted moisturizer broad spectrum SPF 15Clinique International · D-1478-2016
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.